Sonoma Pharmaceuticals Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 78,414
Bid Price 4.84
Ask Price 5.04
News -
Day High 5.115


52 Week Range


Day Low 4.815
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sonoma Pharmaceuticals Inc SNOA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.84 19:44:25
Open Price Low Price High Price Close Price Prev Close
4.86 4.815 5.115 4.98 4.84
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
667 78,414 $ 4.96 $ 388,802 - 4.2001 - 15.19
Last Trade Time Type Quantity Stock Price Currency
19:44:25 formt 250 $ 4.84 USD


Draw Mode:

Sonoma Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 14.99M 3.10M 3.08M $ 20.12M $ -7.36M -1.95 -1.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 5.70k -

more financials information »

Sonoma Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNOA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.355.3654.20014.67164,604-0.51-9.53%
1 Month5.605.884.20015.28179,170-0.76-13.57%
3 Months5.338.764.20016.471,418,796-0.49-9.19%
6 Months7.7613.364.20017.371,726,495-2.92-37.63%
1 Year6.6315.194.20017.751,216,393-1.79-27.0%
3 Years0.7619.540.63997.80520,5684.08536.84%
5 Years4.7119.540.63997.40343,9620.132.76%

Sonoma Pharmaceuticals Description

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.

Your Recent History
Sonoma Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.